Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats

Hypertension

Volumn 35, Issue 2, 2000, Pages 655-661

  Komers, Radko ^a   Oyama, Terry T ^a   Chapman, Justin G ^a   Allison, Kristen M ^a   Anderson, Sharon ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood pressure; Diabetes; Nitric oxide; Nitric oxide synthase; S methyl L thiocitrulline

Indexed keywords

LOSARTAN; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DRUG EFFECT; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NERVE CELL; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; VASOCONSTRICTION;

EID: 0033952017     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.2.655     Document Type: Article

References (48)

1. Pieper GM. Review of alterations of endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 1998;31:1047-1060.
2. Bank N, Aynedjian HS, Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 1993;43:1306-1312.
3. Komers R, Allen TJ, Cooper ME. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes. 1994;43:1190-1197.
4. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol. 1993;265:F886-F895.
5. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-1930.
6. Marletta MA. Nitric oxide: biosynthesis and biological significance. Trends Pharmacol Sci. 1989;158:348-352.
7. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997;100:2146-2152.
8. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
9. Moore PK, Babbedge R, Wallace P, Gaffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. J Pharmacol. 1993;108:296-297.
10. Narayanan K, Spack L, McMillan K, Kilbourn RG, Hayward MA, Masters BS, Griffith OW. S-Alkyl-L-thiocitrullines: potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo. J Biol Chem. 1995;270:11103-11110.
11. Ichihara A, Inscho EW, Imig JD, Navar LG. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol. 1998; 274:F516-F524.
12. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol. 1995;268:F885-F898.
13. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HHHW. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A. 1992;89:11993-11997.
14. Thorup C, Erik A, Persson G. Macula densa derived nitric oxide in regulation of glomerular capillary pressure. Kidney Int. 1996;49: 430-436.
15. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol. 1993;265:F477-F486.
16. 15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
17. Schultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992;90: 1718-1725.
18. Gozal D, Torres JE, Gozal YM, Littwin SM. Effect on nitric oxide synthase inhibition on cardiorespiratory responses in the conscious rat. J Appl Physiol. 1996;81:2068-2077.
19. Beierwaltes WH. Selective neuronal nitric oxide synthesis inhibition blocks furosemide-stimulated renin secretion in vivo. Am J Physiol. 1995;269:F134-F139.
20. Beierwaltes WH. Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthesis. Am J Physiol. 1997;272:R1359-R1364.
21. Ollerstam A, Pittner J, Persson AEG, Thorup C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide. J Clin Invest. 1997;99:2212-2218.
22. Magness RR, Shaw CE, Phernetton TM, Zheng J, Bird IM. Endothelial vasodilator production by uterine and systemic arteries, II: pregnancy effects on NO synthase expression. Am J Physiol. 1997;272: H1730-H1740.
23. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997;17:2479-2488.
24. Okamura T, Ayajiki K, Toda N. Neural mechanism of pressor action of nitric oxide synthase inhibitor in anesthetized monkeys. Hypertension. 1996;28:341-346.
25. Davisson RL, Possas OS, Murphy SP, Lewis SJ. Neurogenically derived nitrosyl factors mediate lumbar sympathetic vasodilation in the hindlimb vasculature of the rat. Am J Physiol. 1997;272:H2369-H2376.
26. Possas OS, Lewis SJ. NO-containing factors mediate hindlimb vasodilation produced by superior laryngeal nerve stimulation. Am J Physiol. 1997;273:H234-H243.
27. Ito S, Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest. 1993;92:1093-1098.
28. Tan DY, Meng S, Manning RD Jr. Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension. Hypertension. 1999;33(pt 2):456-461.
29. DeNicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II: glomerular and tubular interaction in the rat. J Clin Invest. 1992;89: 1248-1256.
30. Sigmon DH, Carretero OA, Beierwaltes WH. Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension. 1992;20: 643-650.
31. Baylis C, Engels K, Samsell L, Harton P. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II. Am J Physiol. 1993;264:F74-F78.
32. Takenaka T, Mitchell KD, Navar LG. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat. J Am Soc Nephrol. 1993;4:1046-1053.
33. Madrid MI, Garcia-Salom M, Tornel J, De Gasparo M, Fenoy FJ. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis. Am J Physiol. 1997;273:R1676-R1682.
34. Yagihashi N, Nishida N, Seo HG, Taniguchi N, Yagihashi S. Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats. Diabetologia. 1996;39:793-799.
35. Blantz RC, Peterson OW, Gushwa L, Tucker BJ. Effect of modest hyperglycemia on tubuloglomerular feedback activity. Kidney Int. 1982; 22(suppl 12):S206-S212.
36. Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol. 1987;252:F65-F73.
37. Vallon V, Blantz RC, Thomson S. Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am J Physiol. 1995;269:F876-F883.
38. Hannedouche T, Lazaro M, Delgado AG, Boitard C, Lacour B, Grunfeld JP. Feedback-mediated reduction in glomerular filtration during acetazolamide infusion in insulin-dependent diabetic patients. Clin Sci. 1991;81: 457-464.
39. Ohishi K, Carmines PK, Inscho EW, Navar LG. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol. 1992;263:F900-F906.
40. Bosse HM, Bachmann S. Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. Hypertension. 1997;30:948-952.
41. Ichihara A, Imig ID, Navar LG. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension. Hypertension. 1999;33(pt 2):462-466.
42. Mattson DL, Roman RJ, Cowley AW. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension. 1992;19:766-769.
43. McKee M, Scavone M, Nathanson JA. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci U S A. 1994; 91:12056-12060.
44. Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol. 1995;6:89-94.
45. Majid DSA, Williams A, Navar LG. Inhibition of nitric oxide synthesis attenuates pressure-natriuretic response in anesthetized dogs. Am J Physiol. 1993;264:F79-F87.
46. Guarasci GR, Kline RL. Pressure natriuresis following acute and chronic inhibition of nitric oxide synthase in rats. Am J Physiol. 1996;270: R469-R478.
47. Mattson DL, Bellehumeur TG. Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension. 1996;28: 297-303.
48. Komers R, Cooper ME. Renal sodium handling in experimental diabetes: role of NO. Nephrol Dial Transplant. 1996;11:2170-2177.